Pregnancy in women with systemic lupus erythematosus

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 101, Issue 2, 2002, Pages 129-134

  Kiss, Emese ^a   Bhattoa, Harjit P ^a   Bettembuk, Peter ^a   Balogh, Adam ^a   Szegedi, Gyula ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Anti 2 glycoprotein antibody; Lupus anticoagulant; Pregnancy; Spontaneous abortion; Systemic lupus erythematosus

Indexed keywords

LUPUS ANTICOAGULANT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; FEMALE; HUMAN; INCIDENCE; INDUCED ABORTION; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0037051130     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00525-5     Document Type: Article

References (52)

1. The influence of sex hormones on the disease systemic lupus ertyhematosus
2. The role of sex hormones in systemic lupus erythematosus
3. Murine lupus: an overview
4. Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice
5. Incidence of systemic lupus erythematosus by age and sex
6. Sex effects in systemic lupus erythematosus: a clue to pathogenesis
7. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus
8. Oral contraceptives and systemic lupus erythematosus
9. Sex steroids and the rheumatic disease
10. Lupus disease activity associated with menstrual cycle
11. Effect of pregnancy on the course of systemic lupus erythematosus
12. Frequency of lupus flare in pregnancy: The Hopkins Lupus Pregnancy Center experience
13. Pregnancy does not cause systemic lupus erythematosus to worsen
14. Pregnancy and systemic lupus erythematosus
15. Outcome of pregnancy in patients with systemic lupus erythematosus. A perspective study
16. Perinatal outcomes in women with systemic lupus erythematosus
17. Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases
18. Pregnancy in patients with systemic lupus erythematosus
19. Antibody to cardiolipin as a predictor of foetal distress or death in pregnant patients with systemic lupus erythematosus
20. Antiphospholipid antibodies in recurrent fetal loss: only one side of the coin
21. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus
22. A study of 100 high risk lupus pregnancies
23. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients
24. A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus
25. Obstetric outcome in antiphospholipid syndrome
26. Antiphospholipid syndrome in SLE
27. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SSA/Ro and to SSB/La
28. Neonatal lupus erythematosus: HLA-DR and -DQ distributions are different among the groups of anti-Ro/SSA-positive mothers with different neonatal outcomes
29. Systemic lupus erythematosus and pregnancy
30. Pregnancy in lupus
31. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
32. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the standardization of lupus anticoagulants
33. Association of anti-beta 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
34. Systemic lupus erythematosus in a boy with chronic granulomatous disease: a case report and review of the literature
35. Neonatal risk to newborns of mothers with systemic lupus erythematosus
36. Systemic lupus and pregnancy
37. Clinical predictors of fetal outcome in systemic lupus erythematosus
38. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases
39. Interleukin-3 and pregnancy loss in antiphospholipid syndrome
40. The risk of cytotoxic drugs during pregnancy
41. Antimalarial drugs in pregnancy: the North American experience
42. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus
43. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases
44. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialoadenitis in autoimmune MRL lpr/lpr mice
45. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus
46. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE
47. Can women with systemic lupus erythematosus safely use exogenous estrogens?
48. Hormone replacement therapy in systemic lupus erythematosus
49. Clinical features of systemic lupus erythematosus patients with a disease duration more than 10 years
50. Protection of ovarian failure by oral contraceptives in women receiving chemotherapy for Hodgkin's disease
51. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus